Denali-Sanofi's ALS drug fails to meet mid-stage trial goal

Denali-Sanofi's ALS drug fails to meet mid-stage trial goal

Submitted by admin on February 16, 2024 - 11:36am
Source: 
Reuters
News Tags: 
Denali Therapeutics
Sanofi
ALS
clinical trials
Headline: 
Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
snippet: 

 Drug developer Denali Therapeutics (DNLI.O) said on Friday its and partner Sanofi's (SASY.PA) experimental drug for a fatal neurodegenerative disease failed to slow decline of motor function in a mid-stage study.

Do Not Allow Advertisers to Use My Personal information